搜索筛选:
搜索耗时0.0768秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in p
[会议论文] 作者：Xian Liu,Gang Ren,Liqin Li,Tingyi Xia,
来源：2016年北京市肿瘤放疗年会 年份：2016
To better guide the development and optimization of radiotherapy planning, to reduce the incidence of radiation reactions, and to improve the quality of life of the patients with pancreatic cancer usi...
[会议论文] 作者：Fengming Lan,Huiming Yu,Man Hu,Tingyi Xia,Xiao Yue,
来源：2015年北京放射肿瘤年会 年份：2016
The study aimed to explore the specific function and mechanism of miR-144-3p in glioblastoma (GBM) cells with different phosphatase and tensin homolog (PTEN) phenotypes.We demonstrated that the miR-14...
[会议论文] 作者：Tingyi Xia,Yingjie Wang,Hongqi Li,Jing Li,Dongshu Chang,Xuan Wang,Weizhang Wu,
来源：第三届亚洲辐射研究大会 年份：2013
Purpose: To evaluate the efficacy and radiation side effect of patients with stage Ⅰ/Ⅱ Non-small cell lung cancer (NSCLC) and lung metastases treated with hypofractionated γ-ray stereotactic body radi...
miR-15a/16 Enhances Radiation Sensitivity of Non-Small Cell Lung Cancer Cells by Targeting the TLR1/
[会议论文] 作者：Fengming Lan,Xiao Yue,Gang Ren,Hongqi Li,Li Ping,Yingjie Wang,Tingyi Xia,
来源：2015年北京放射肿瘤年会 年份：2016
Purpose: Many miRNAs have been identified as essential issues and core determining factors in tumor radiation.Recent reports have demonstrated that miRNAs and Toll-like receptors could exert reciproca...
A Multi-institution, Randomized Phase 3 Study Comparing Two Schedules of Low-dose Radiosensitizing P
[会议论文] 作者：,Huimin Ma,Anhui Shi,Jianhao Geng,Guangying Zhu,Yuhchyau Chen,Jiancheng Li,Hang Li,Yingjie Wang,Tingyi Xia,
来源：中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份：2015
...
A Multi-institution, Randomized Phase 3 Study Comparing Two Schedules of Low-dose Radiosensitizing P
[会议论文] 作者：Lin,Yuhchyau Chen,Anhui Shi,Guangying Zhu,Rong Yu,Yannan Yuan,Jiancheng Li,Hang Li,Yingjie Wang,Tingyi Xia,
来源：中华医学会第十二次全国放射肿瘤学治疗学学术会议 年份：2015
Background Concurrent chemoradiotherapy (CCRT) is the current standard therapy for locally advanced non-small cell lung cancer (LA-NSCLC), but chest tumor failure rates remain disappointingly high (＞5...
相关搜索：
